ask="3.60"
ask_size="500"
average_daily_volume="216367"
bid="2.80"
bid_size="500"
book_value="-0.12"
change="-0.05"
change_from_200_day_moving_average="-0.03"
change_from_50_day_moving_average="0.03"
change_from_52_week_high="-1.03"
change_From_52_week_low="0.65"
change_in_percent="-1.61%"
close="3.05"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.95"
ebitda="-29.91M"
eps_estimate_current_year="-1.04"
eps_estimate_next_quarter="-0.25"
eps_estimate_next_year="-0.92"
ex_dividend_date="N/A"
float_shares="26692000"
high="3.15"
high_52_weeks="4.08"
last_trade_date="3/15/2017"
last_trade_price="3.05"
last_trade_size="6572"
last_trade_time="4:00pm"
low="3.05"
low_52_weeks="2.40"
market_capitalization="138.27M"
moving_average_200_day="3.08"
moving_average_50_day="3.02"
name="AcelRx Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.80"
open="3.10"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-0.95%"
percent_change_from_50_day_moving_average="+0.99%"
percent_change_from_52_week_high="-25.23%"
percent_change_from_52_week_low="+27.08%"
previous_close="3.10"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="8.10"
revenue="17.36M"
shares_outstanding="45336000"
short_ratio="18.63"
stock_exchange="NGM"
symbol="ACRX"
volume="119287"
weeks_range_52="2.40 - 4.08"
